Studies suggest that in estrogen receptor-positive (ER-positive) breast cancer, RORA may enhance cancer cell proliferation through the upregulation of aromatase expression, potentially contributing to tumorigenesis [18].In contrast, RORA displays tumor-suppressive activity in other cancer types. Here, CYP19A1 is linked to cancer.